Compare Archi Indonesia Tbk (ARCI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Archi Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Archi Indonesia Tbk trades at Rp930 (market cap 24.86T, 21.8M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 160.57B, 2.51M 24h volume). The key difference: Archi Indonesia Tbk is far larger — about 154.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Archi Indonesia Tbk is more actively traded (21.8M versus 2.51M). Which is the better fit depends on your goals.
| ARCI | OBAT | |
|---|---|---|
Market Cap | 24.86T | 160.57B |
Volume | 21.8M | 2.51M |
Lot | 218.04K | 25.09K |
Turnover | 20.81B | 636.74M |
Average Price | 954.51 | 253.78 |
Value | 20.81B | 636.74M |
Indicative Equilibrium Price | 930 | 242 |
Indicative Equilibrium Volume | 5.48K | 146 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Archi Indonesia Tbk
PT Archi Indonesia Tbk. (the Company) was established based on Notarial Deed No. 1 of Fatma Agung Budiwijaya, S.H., dated September 14, 2010. The Company commenced its commercial operations in 2010 and is primarily involved in investment holding. PT Rajawali Corpora is the Companys parent and ultimate parent entity.
Read more on ARCI →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
